We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
-12.16%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$239M
AUM Growth
-$43.8M
Cap. Flow
+$9.39M
Cap. Flow %
3.93%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$16.2M

Top Sells

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$6.84M
2
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$12

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$112M 46.71%
852,708
– –
PCVX icon
2
Vaxcyte
PCVX
$8.81B
$26.4M 11.06%
1,111,485
-293,936
-21% -$6.84M
RLYB icon
3
Rallybio
RLYB
$87M
$21.7M 9.06%
283,914
– –
EXAI
4
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$15.3M 6.38%
+772,285
New +$16.2M
AKUS
5
DELISTED
Akouos Inc
AKUS
$15.3M 6.38%
1,794,088
– –
ARQT icon
6
Arcutis Biotherapeutics
ARQT
$3.3B
$11.8M 4.93%
569,041
– –
INZY
7
DELISTED
Inozyme Pharma
INZY
$10.9M 4.54%
1,591,154
– –
ALGS icon
8
Aligos Therapeutics
ALGS
$45.5M
$10.4M 4.35%
35,062
– –
BOLT icon
9
Bolt Biotherapeutics
BOLT
$7.65M
$9.27M 3.88%
94,573
– –
FUSN
10
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$6.51M 2.72%
1,598,377
-2
-0% -$12

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q4 2021 Portfolio in Review

As of Q4 2021, Pivotal bioVenture Partners Investment Advisor held 10 positions worth $239M, down 15% from $283M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pivotal bioVenture Partners Investment Advisor deployed $9.39M of net new capital in Q4 2021, opening 1 new position. Its largest new stake was Exscientia Plc American Depositary Shares: 772,285 shares worth $15.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Vaxcyte, an estimated $6.84M trimmed.

  • Pivotal bioVenture Partners Investment Advisor's largest Q4 2021 buy was Exscientia Plc American Depositary Shares: 772,285 shares worth $15.3M.
  • Pivotal bioVenture Partners Investment Advisor's biggest Q4 2021 reduction was Vaxcyte, cutting an estimated $6.84M.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 100% of its $239M portfolio in Q4 2021.
  • Pivotal bioVenture Partners Investment Advisor opened 1 new position and closed 0 in Q4 2021.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value fell 15% quarter-over-quarter to $239M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q4 2021, filed 14 Feb 2022.